Meta-analysis evaluates cannabidiol's effects on psychotic symptoms in randomized controlled trials, implying more research is necessary.
Despite the limited number of outcomes assessed at the current state of the evidence, CBD did not show a clear benefit for psychosis symptoms in RCTs but was generally well tolerated. Larger, high-quality trials are needed to reach more robust conclusions about CBD efficacy in these disorders.
No takes yet. Share an insight, caveat, or question.
Marchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: